SB 202190 200 mg | 99.55%
TargetMol
SB 202190 is a selective and cell-permeable inhibitor of p38 MAPK (IC50s: 50/100 nM for p38α/p38β).
More Information Supplier PageSB 202190
Search Results
SANT-1 10 mg | 100.00%
TargetMol
SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).
More Information Supplier PageSANT-1
SANT-1 25 mg | 100.00%
TargetMol
SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).
More Information Supplier PageSANT-1
SANT-1 2 mg | 100.00%
TargetMol
SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).
More Information Supplier PageSANT-1
SANT-1 5 mg | 100.00%
TargetMol
SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).
More Information Supplier PageSANT-1
Ddr1-In-1 10 mg | Purity Not Available
TargetMol
DDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.
More Information Supplier PageDdr1-In-1
Ddr1-In-1 50 mg | Purity Not Available
TargetMol
DDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.
More Information Supplier PageDdr1-In-1
Ddr1-In-1 5 mg | Purity Not Available
TargetMol
DDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.
More Information Supplier PageDdr1-In-1
NSC 228155 10 mg | 99.84%
TargetMol
NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.
More Information Supplier PageNSC 228155
NSC 228155 200 mg | 99.84%
TargetMol
NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.
More Information Supplier PageNSC 228155
